{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:07:01Z","timestamp":1780628821640,"version":"3.54.1"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020975","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020975","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2023.2259609","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:22:25Z","timestamp":1694780545000},"page":"1190-1200","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-4901","authenticated-orcid":false,"given":"Valgerdur","family":"Sigurdardottir","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Falun Hospital, Centre for Clinical Research, Dalarna, Uppsala University, Falun, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Engstrom","sequence":"additional","affiliation":[{"name":"UCB Pharma, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patric","family":"Berling","sequence":"additional","affiliation":[{"name":"UCB Pharma, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9919-4487","authenticated-orcid":false,"given":"Tor","family":"Olofsson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lund University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6194-0982","authenticated-orcid":false,"given":"Linnea","family":"Oldsberg","sequence":"additional","affiliation":[{"name":"Quantify Research, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-8507","authenticated-orcid":false,"given":"Susannah","family":"Sadler","sequence":"additional","affiliation":[{"name":"Cytel, London, England, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-8441","authenticated-orcid":false,"given":"Devian","family":"Parra-Padilla","sequence":"additional","affiliation":[{"name":"Cytel, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Melis","sequence":"additional","affiliation":[{"name":"UCB Pharma, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-4047","authenticated-orcid":false,"given":"Damon","family":"Willems","sequence":"additional","affiliation":[{"name":"UCB Pharma, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8630-7"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.221139"},{"key":"e_1_3_6_5_1","unstructured":"Statistics Sweden. Official Statistics of Sweden: population: statistics Sweden; 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/www.statistikdatabasen.scb.se\/pxweb\/en\/ssd\/START__BE\/."},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3682"},{"issue":"6","key":"e_1_3_6_7_1","first-page":"809","article-title":"Longitudinal study of clinical and radiological progression in psoriatic arthritis","volume":"17","author":"Gladman DD","year":"1990","unstructured":"Gladman DD, Stafford-Brady F, Chang CH, et\u00a0al. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol. 1990;17(6):809\u2013812.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg217"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/30.4.245"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01422-z"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1468252"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.05.010"},{"issue":"3","key":"e_1_3_6_13_1","first-page":"342","article-title":"Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis","volume":"32","author":"Kennedy M","year":"2014","unstructured":"Kennedy M, Papneja A, Thavaneswaran A, et\u00a0al. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clin Exp Rheumatol. 2014;32(3):342\u2013348.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg384"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150406"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30949-8"},{"key":"e_1_3_6_17_1","unstructured":"Swedish Rheumatology Association. Guidelines and recommendations: psoriatic arthritis \u2013 guidelines for drug treatment: Swedish Rheumatology Association; 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/riktlinjer.svenskreumatologi.se\/riktlinjer-och-rekommendationer\/psa\/."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217163"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13185"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02302-9"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02303-0"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42280"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33161-7"},{"key":"e_1_3_6_25_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP). European public assessment reports: bimzelx. Procedure No. EMEA\/H\/C\/005316\/II\/0011 European Medicines Agency 2023 [cited 2023 28\/07\/2023]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/bimzelx-h-c-5316-ii-0011-epar-assessment-report-variation_en.pdf."},{"key":"e_1_3_6_26_1","unstructured":"European Medicines Agency. Summary of product characteristics: bimzelx: european Medicines Agency; 2023 cited 2023 28\/07\/2023]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimzelx-epar-product-information_en.pdf."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.03.2280"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab119"},{"key":"e_1_3_6_29_1","unstructured":"Central European Bank. Average exchange rates - SEK to Euro 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/www.ecb.europa.eu\/stats\/policy_and_exchange_rates\/euro_reference_exchange_rates\/html\/eurofxref-graph-sek.en.html."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.03.021"},{"key":"e_1_3_6_31_1","author":"Dental and Pharmaceutical Benefits Agency (TLV)","year":"2017","unstructured":"Dental and Pharmaceutical Benefits Agency (TLV). Amendment to the Dental and Pharmaceutical Benefits Agency\u2019s General Advice (TLVAR 2003:2) on Economic Evaluations; 2017 [cited 2023 Sep 20]. Available from: https:\/\/www.tlv.se\/download\/18.467926b615d084471ac3230c\/1510316374332\/TLVAR_2017_1.pdf","journal-title":"Amendment to the Dental and Pharmaceutical Benefits Agency\u2019s General Advice (TLVAR 2003:2) on Economic Evaluations"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.1686"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-018-0114-y"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.02.001"},{"key":"e_1_3_6_36_1","volume-title":"Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs","author":"National Institute for Health and Care Excellence (NICE)","year":"2021","unstructured":"National Institute for Health and Care Excellence (NICE). Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs. Technology appraisal guidance [TA711]. London (UK); 2021."},{"key":"e_1_3_6_37_1","unstructured":"Swedish Electronic Medicines Compendium (FASS). Drugs database: swedish Electronic Medicines Compendium (FASS); 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/www.fass.se\/LIF\/startpage."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta15100"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22800"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.048975"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031237"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151979"},{"key":"e_1_3_6_43_1","volume-title":"Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs","author":"National Institute for Health and Care Excellence (NICE)","year":"2021","unstructured":"National Institute for Health and Care Excellence (NICE). Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs. Technology appraisal guidance (TA768). 2021. London, United Kingdom."},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30265-8"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30263-4"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem221"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker245"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.10.016"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0496-4"},{"key":"e_1_3_6_50_1","unstructured":"Dental and Pharmaceutical Benefits Agency. (Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverket T. Price and decision database: dental and Pharmaceutical Benefits Agency (Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverket TLV); 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/www.tlv.se\/beslut\/sok-priser-och-beslut-i-databasen.html."},{"key":"e_1_3_6_51_1","unstructured":"Region Stockolm and Gotland. Price list Contract drugs Region Stockholm and Region Gotland Region Stockolm and Gotland; 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/contracts.tendsign.com\/ContractArea\/Details\/1579312?eId=2XwXmS0zykSquwLRsSricwA%3d."},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150617"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1591"},{"key":"e_1_3_6_54_1","unstructured":"S\u00f6dra sjukv\u00e5rdsregionen. Regionala priser och ers\u00e4ttningar f\u00f6r s\u00f6dra sjukv\u00e5rdsregionen: s\u00f6dra sjukv\u00e5rdsregionen; 2022 [cited 2023 28\/07\/2023]. Available from: https:\/\/sodrasjukvardsregionen.se\/download\/regionala-priser-och-ersattningar-for-sodra-sjukvardsregionen-2022\/?wpdmdl=24791&masterkey=61decc148fc78."},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0618-5"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-018-0162-3"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00202-1"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqi171"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2023.2259609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T09:55:30Z","timestamp":1701942930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2023.2259609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2023.2259609"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2023.2259609","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}